Phase 2 randomized controlled multi-center study of IS-002, in conjunction with near-infrared
(NIR) fluorescence imaging, for identification of prostate cancer during robotic-assisted
radical prostatectomy (RARP) with (extended) pelvic lymph node dissection ((e)PLND) using the
da Vinci® X/Xi Surgical System with Firefly® Fluorescence Imaging.